Clinical Trial Update: A Phase I Study to Assess the Electrophysiologic Effects of BMS-394136 on the Atrium and Ventricle in Patients With Dual-Chamber Pacemakers or Defibrillators [Phase 1]

View source ↗

Summary

A Phase I study assessed the electrophysiologic effects of BMS-394136 on the atrium and ventricle in patients with dual-chamber pacemakers or defibrillators; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Disease

Drugs mentioned

• BMS-394136

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Heart Diseases | Phase 1 | Status: COMPLETED